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Abstract
Background: Smoking is known to aggravate tuberculosis (TB), but such information has been ignored in clinical 
practice, as it was not thought to be relevant. The aim of this study is to assess the benefits of smoking cessation on TB 
mortality reduction.
Methods: The study attempts to quantify smokers' risks on subsequent TB mortality and the change in such risks after 
smokers quit smoking. In this prospective cohort study, the TB mortality risks of smokers, never smokers and former 
smokers were compared, by using the Cox proportional model to estimate the hazard ratio (HR) of TB.
The cohort, consisting of 486,341 adults, participated in standard medical screening programs since 1994, including
5,036 with self-reported TB history. Of 15,268 deaths identified as of 2007, 77 were coded as TB.
Results: Smokers with self-reported TB history (1.2%) had very high TB mortality (HR = 44.02). Among those without 
self-reported TB history, smoking increased TB mortality by nine-fold (HR = 8.56), but when they quit smoking, the risk 
was reduced by more than half (65%), to a level not different from those who had never smoked. The overwhelming 
majority of TB deaths (83%) occurred among those without self-reported TB history. Given the high smoking 
prevalence and the high HR, smoking accounted for more than one-third (37.7%) of TB mortality in Taiwan. Smokers 
reported less TB history but died more from TB than those who had never smoked.
Conclusions: Smokers had very high TB mortality, as much as nine times those who had never smoked, but once they 
quit, the risk reduced substantially and was similar to those who never smoked. Smoking cessation has benefits to the 
smokers far beyond reducing TB risk, but successful tobacco control could favorably impact the TB mortality rate and 
reduce this public health burden, which has long haunted the Taiwanese population. Smoking cessation could reduce 
nearly one-third of tuberculosis deaths.
Background
Although the relationship between smoking and TB has
been extensively reviewed [1-5], most studies have deter-
mined that a strong relationship exists between smoking
and TB based more on case control study design than
cohort one, studying more active TB diseases than TB
deaths [2]. One of the difficulties is that in countries other
than India or China, deaths attributable to TB are rela-
tively rare and the number of TB deaths is small, making
statistical power difficult to reach in epidemiological
studies [2]. As there was limited evidence on TB mortal-
ity from cohort studies [6-8], the clinical significance of
reducing smoking on TB mortality was largely unrecog-
nized [9]. Whether smoking was viewed as a risk factor
for TB relapse was also not fully established [10]. This is
due to the fact that since TB is a treatable disease[9], the
role of smoking as a risk factor for TB disease was mostly
perceived as irrelevant. To clinicians who focused on
treating TB, reducing smoking was considered as a sepa-
rate issue, not shown to be directly beneficial. The use of
a cohort becomes particularly valuable because a cohort
could show not only the effect of smoking in increasing
the risks of TB disease [11] or mortality [12] but also it
could provide the opportunity to examine TB risks
among smokers who quit smoking, which would be of
value for clinicians to apply in clinical practice.
Smoking caused 5 million deaths a year [13], and tuber-
culosis, nearly 2 million deaths a year [2]. Globally, one-
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third of smokers and one-fifth of TB prevalence cases
(patients) are in East Asian countries in 2000 [14]. As
many as one-third of the Chinese population is estimated
to be infected with TB [3,15,16], known to be aggravated
by smoking during its natural course [15,17]. Given that
TB and smoking are two major preventable killers, it is
disappointing that only recently their relationship started
to receive attention in research papers, mostly from India
[2,18] and East Asia [12,19,20]. The relationship took on
an increasing importance in China where the interaction
on outcome between tens of millions of TB patients,
some known but mostly unknown, and 350 million smok-
ers [21] is largely ignored, and therefore, the potential to
reduce the large number of TB deaths in China, estimated
at 200,000 in a given year, has been left unexplored [14].
Health care workers focused on TB have rarely consid-
ered the impact of smoking cessation on these patients.
The objective of this study is to assess the effect of
smoking on TB mortality and the benefit of smoking ces-
sation by following a healthy Chinese cohort. Because
having TB history (or known TB patient) is a major con-
founder, we were particularly interested in examining the
reduction of TB risks among those without TB history
after they quit smoking.
Methods
Characteristics of the participants
The cohort, consisting of 486,341 adults, aged 20 and
older, went through standard medical screening pro-
grams run by a private firm, MJ Health Management
Institution, Taipei, Taiwan (MJ), since 1994. The firm
attracted paying participants from all over Taiwan and
across socioeconomic classes, because of its known qual-
ity and accessible key facilities. Details of the cohort have
been reported elsewhere [22].
All participants had basic demographic information,
and received a panel of comprehensive blood and anthro-
pometric measurement. Body Mass Index (BMI) was cal-
culated from weight (kg)/height (m)2. A written
questionnaire was drafted in 1996, including one ques-
tion on whether they have had TB. Questionnaire data on
smoking (79%), drinking (79%) or TB history (86%) were
available on a majority of the cohort subjects. The actual
available data was used to arrive at the percentages.
Two levels of diabetes were identified: those by self-
reported history, including taking medication for that
condition, and those discovered by screening tests. The
total number of diabetics was those with history and
those identified by fasting glucose at or above 126 mg/dl.
Social economic status and smoking/TB history
Education was used as surrogates for social class and
classified as: middle school or lower (9 years of education
or less), high school (10-12 years), junior college (13-14
years) and college or higher (16 or more years of educa-
tion). Number of years and number of cigarettes smoked
per day were collected from both the current smokers
and ex-smokers. We used (ever smokers) to represent
smokers and ex-smokers. Current smokers were those
reported (smoking daily) and were asked to give number
of years and number of cigarettes smoked per day. Ex-
smokers were smokers who had already quit. Regular
drinkers were those who drank more than two drinks
each time for at least three times a week. Occasional
drinkers drank less than regular drinkers. Self-reported
TB history was collected from the questionnaire. Self-
reported TB history was defined as being aware of or
remembered of TB history when the participants were
first enrolled in this study.
Mortality rate
Taiwan has a national death file in electronic form avail-
able from the Department of Health which records
deaths since 1971 [23]. With the use of unique individual
ID numbers, the vital status of the cohort was obtained as
of the end of 2007, with an accumulated 3,853,845 person
years and a median follow-up of 8.5 years. Cause of death
was coded according to 9th revision of International
Classification of Disease (ICD-9). Although TB deaths
included ICD-9: 010-018, all TB deaths in this study were
limited to pulmonary TB (ICD-9: 011). The age-specific
mortality for TB for men and women in Taiwan, for the
period 1994-2007, came from the Taiwan Department of
Health [23].
Statistical analysis
The study attempts to quantify the smoker's risks on sub-
sequent TB mortality and the change in such risks after
smokers quit smoking. In this prospective cohort study,
the TB mortality risks of smokers, never smokers and for-
mer smokers were compared by using the Cox propor-
tional model to estimate the hazard ratio (HR) of TB. HRs
were presented first with age and gender adjustment and
then with the additional education, drinking, BMI and
diabetes mellitus history adjustment. Smoking attribut-
able fraction for TB mortality was calculated from the
formula: Prevalence × (HR - 1)/{1 + [Prevalence × (HR -
1)]} where prevalence was the national prevalence for
smoking in Taiwan [24].
Ethical issues
Every participant had signed a consent form authorizing
MJ to process the data. The Institutional Review Board of
the National Health Research Institute processed and
approved the study. Individual names were removed early
in the process and the entire analyses were conducted
with anonymous data.Wen et al. BMC Infectious Diseases 2010, 10:156
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Results
Self-reported TB
Characteristics of the subjects in the cohort, 486,341,
were compared with those reporting positive TB history,
5,036 (1.20%), and the differences expressed as odds ratio
(OR) in Table 1. Self-reported TB history increased
sharply with increasing age. Men reported more TB than
women by 79%. Below age 40, lower educated reported
more TB history, but above age 40, higher educated
reported more TB history. Because of this cross over, the
relationship between TB history and education was not
consistent across age groups. Out of 384,855 adults with
smoking history in the cohort, 90,580 (23.5%) were cur-
rent smokers and 23,787 (6.2%) were ex-smokers. Cur-
rent smokers reported significantly less TB history, with
23% (OR: 0.77) less than those who had never smoked.
Self-reported TB history increased when drinking
increased. A lower BMI was associated with higher
r e p o r t e d  T B  h i s t o r y .  T h o s e  w i t h  k n o w n  d i a b e t e s
reported more TB history by 17%, compared against
those with no diabetes.
Smoking status and TB mortality risks
Table 2 shows the hazard ratios by smoking status on
total cohort, and on sub-cohort with or without self-
r e p o r t e d  T B  h i s t o ry  f o r  T B  m o r t a l i t y .  C o m p a r e d  w i t h
those who had never smoked, current smokers showed
significantly increased deaths from TB, 3.37 (95% CI:
1.4~8.1) for current smokers (when age, gender, educa-
tion and drinking, BMI and diabetes history were
adjusted). The group that reported smoking the least,
those smoking less than half a pack a day (HR = 3.70),
those smoking less than 10 years (HR = 2.38), or those
smoking less than 15 packs per year (HR = 2.54) showed
substantially increased TB mortality risks.
For those with no prior TB history , the risk of dying
from TB among current smokers increased more than
nine-fold, with HR at 8.56 (95% CI: 2.5~29.8), when com-
pared with those who had never smoked. When these
smokers quit smoking, the ex-smokers' TB risk (HR =
3.03) reduced significantly by 65% compared to current
smokers. [The hazard ratio between ex-smokers and cur-
rent smokers in this case was 0.26 (95% CI: 0.1~0.9). Data
not shown]. The TB risk of ex-smokers was not much dif-
ferent from those who had never smoked, both in the
total cohort (HR = 2.02, 95% CI: 0.7~6.0) and in those
with no TB history (HR = 3.03, 95% CI: 0.6~15.3).
The combined effect of smoking and TB history (HR =
44.02) in increasing TB mortality was larger than either
smoking (HR = 8.56) or TB history alone (HR = 29.47),
indicative of interaction between smoking and TB. When
those with positive TB history were compared with those
without, TB mortality increased by nearly 6-fold (5.90,
95% C.I.; 3.1~11.2). The risk of current smokers (HR =
10.10) doubled that of those who had never smoked (HR
= 4.75) but reduced by 45% when they became ex-smok-
ers (HR = 5.51) as the result of smoking cessation.
Selected risk factors and TB mortality risks
Table 3 lists hazard ratios for selected risk factors related
to TB mortality other than smoking. From the national
data, the age-specific TB mortality rate increased sharply
with increasing age, by approximately 150-300 times
between age 20-29 and age 70+. Men had much higher
rates than women, and, for age 60-69, the difference was
approximately five-fold. Lower educated patients (middle
school or below) had a TB mortality rate approximately
three times more than higher educated patients. Drink-
ing, significantly related to TB history, was also related to
TB mortality, but did not reach the significance level. Low
BMI patients, <18.5 kg/m2, had nearly a 10-fold increase
in mortality, but overweight or obese patients were asso-
ciated with reduced mortality. Diabetic patients, combin-
ing known cases and those discovered through screening,
had 89% increased mortality from TB. The smoking
attributable fraction for TB, when projected to Taiwan as
a nation, was 37.7% (Table 4), given the national preva-
lence of 25.6% for current smokers [25].
Discussion
Smokers had very high TB mortality, as much as nine
times those who had never smoked, but once they quit,
the risk reduced substantially and was similar with those
who never smoked. The 65% reduction of TB mortality
risk as the result of smoking cessation was substantial and
statistically significant. That TB risk could be reduced by
nearly two-third if one quits smoking is a compelling evi-
dence in highlighting the important role of smoking in
TB control [26]. As smoking was responsible for more
than one-third of TB deaths in Taiwan (37.7%), successful
tobacco control in reducing smoking could favorably
impact the TB mortality rate and reduce nearly one-third
(30.7%) of this public health burden, which has long
plagued the Taiwanese population. This large public
health impact will be even larger, when applied to coun-
tries like China, where the prevalence of smoking and
rates for TB are higher. Smoking cessation has been dem-
onstrated for reducing TB incidence [27], but this study
extended the benefit of smoking cessation on reducing
TB mortality. With two-thirds of Chinese males smoking
[21] and about three million TB cases, our observation
should change the course of practice guidelines for man-
aging active TB in the Chinese population. This is re-con-
firmed by our finding that smoking substantially
aggravated TB mortality risks among those with TB his-
tory (from HR = 4.75 to HR = 10.10).
The size of the hazard ratio, 3.37 among the entire
cohort or 8.56 among those with no TB history, is largerWen et al. BMC Infectious Diseases 2010, 10:156
http://www.biomedcentral.com/1471-2334/10/156
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Table 1: Comparison of the characteristics of the total cohort, 486, 341 subjects, with those having a past history for TB, 
5,036 subjects
Total cohort Self reported
TB history (+)
(%)‡ OR† (95%C.I.)
Age 486,341 5,036 (1.20)
20-29 113,361 455 (0.45) 1 -
30-39 149,192 1,072 (0.81) 1.74* (1.6~1.9)
40-49 87,217 981 (1.30) 2.77* (2.5~3.1)
50-59 71,350 958 (1.60) 3.44* (3.1~3.9)
60-69 47,610 967 (2.54) 5.05* (4.5~5.6)
70+ 17,611 603 (4.38) 8.39* (7.4~9.5)
Gender 486,341 5,036 (1.20)
Women 255079 1918 (0.88) 1 -
Men 231262 3118 (1.55) 1.79* (1.7~1.9)
Education 399,135 4,969 (1.24)
High school or above 291,711 3,364 (1.15) 1 -
Middle school or below 107,424 1,605 (1.49) 0.48* (0.4~0.5)
Smoking 384,855 4,768 (1.24)
Non smokers 270,488 3,148 (1.16) 1 -
Ex smokers 23,787 561 (2.36) 1.17* (1.1~1.3)
Current smokers 90,580 1,059 (1.17) 0.77* (0.7~0.8)
Drinking 379,996 4,720 (1.24)
Nondrinker 296,235 3,349 (1.13) 1 -
Ex-drinker 11,599 249 (2.15) 1.16* (1.0~1.3)
Occasional drinker 56,050 848 (1.51) 1.04 (1.0~1.1)
Regular drinker 16,112 274 (1.70) 1.15* (1.0~1.3)
Body Mass Index 485,080 5,031 (1.20)
<18.5 kg/m2 39,565 575 (1.62) 1.78* (1.6~2.0)
18.5 -< 23 kg/m2 214,250 2,452 (1.32) 1 -
23 -< 25 kg/m2 98,734 1,007 (1.19) 0.65* (0.6~0.7)
25 -< 30 kg/m2 113,897 904 (0.94) 0.47* (0.4~0.5)
^30 kg/m2 18,634 93 (0.59) 0.34* (0.3~0.4)
Diabetes 483,641 5,036 (1.20)
No history of diabetes 476,434 4,827 (1.18) 1 -
Known diabetes or on medications 9,907 209 (2.11) 1.17* (1.0~1.4)
*: p < 0.05
† : OR: the likelihood of having TB history for those with a given variable against those without the given variable, adjusted for age
‡ The actual number of available subjects was used to arrive at the percentages. Questionnaires were administered as of 1996. Thus, during 
the start-up period of two years, 1994-1996, data on a proportion of subjects were missing. TB history (14%), education (18%), smoking (21%), 
and drinking (21%).
BMI and diabetes were more than 99% complete for total cohort.W
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Table 2: Hazard ratios (HR) by smoking status on total cohort, and on sub-cohort with self-reported TB history for TB mortality
Total cohort (486,341) Sub-cohort who responded to TB history question
self reported TB 
history (-)
414,460
Self reported TB history (+)
5,036
Self reported
TB history (-)
414,460
Self reported
TB history (+)
5,036
N HR† (95%C.I.) HR‡ (95%C.I.) N HR§ N HR§ (95%C.I.) HR|| (95%C.I.) HR|| (95%C.I.)
Hazard ratio- TB deaths TB deaths
(77)
64 1 13 5.90* (3.1~11.2)
Never smoker** 8 1 - 1 -3 - 5 4.75* (1.9~12.0) 1 - 29.47* (6.9~125.2)
Current smoker** 21 4.19* (1.8~9.7) 3.37* (1.4~8.1) 17 - 4 10.10* (3.3~30.8) 8.56* (2.5~29.8) 44.02* (9.6~201.6)
Ex-smoker** 6 1.90 (0.6~5.6) 2.02 (0.7~6.0) 3 - 3 5.51* (1.6~18.4) 3.03 (0.6~15.3) 29.25* (5.7~149.0)
Ever smoker** 27 3.97* (1.9~8.4) 2.62* (1.2~5.9)
Current smoker**
<half a pack/day 10 5.35* (2.0~14.1) 3.70* (1.4~10.0)
half a pack/day 11 2.88* (1.1~7.5) 1.84 (0.7~5.0)
<10 years of smoking 1 3.01 (0.4~25.0) 2.38 (0.3~20.1)
10 years of smoking 20 3.74* (1.6~8.9) 2.44 (1.0~6.0)
<15 pack-year 4 3.51* (1.0~12.1) 2.54 (0.7~8.9)
15 pack-year 17 3.83* (1.6~9.3) 2.46 (1.0~6.2)
*: p < 0.05 † : HR adjusted for age and gender, with nonsmokers as reference group;
‡ : HR adjusted for age, gender, education, drinking, BMI and DM history with nonsmokers as reference group
§ : HR adjusted for age, gender, education, drinking, BMI and DM history, with those with TB history (-) as reference group;
||: HR: adjusted for age, gender, education, drinking, BMI and DM history, with those nonsmokers with TB history (-) as reference group
** The actual number of subjects with smoking history was used to calculate HRsW
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Table 3: Hazard ratios (HR) for selected risk factors related to TB mortality other than smoking
N Number of TB 
deaths
TB mortality in Taiwan
(1994 -- 2007) §
HR† (95%C.I.) HR‡ (95%C.I.)
Age 486,341 Male Female
20-29 113,361 1 0.3 0.2
30-39 149,192 2 1.4 0.5
40-49 87,217 2 3.3 0.8
50-59 71,350 11 7.7 1.7
60-69 47,610 24 25.9 5.3
70+ 17,611 37 102.6 32.9
Gender 486,341
Women 255079 12 1 - 1 -
Men 231262 65 5.69 * (3.1~10.5) 8.39 * (1.7~40.3)
Education 399,135
High school or above 291,711 6 1.00 - 1.00 -
Middle school or below 107,424 30 3.38 * (1.4~8.2) 2.51 * (1.0~6.3)
Drinking 379,996
Nondrinker 296,235 16 1 - 1 -
Ex-drinker 11,599 4 1.73 (0.6~5.3) 1.49 (0.5~4.6)
Occasional drinker 56,050 12 1.74 (0.8~3.8) 1.41 (0.6~3.2)
Regular drinker 16,112 2 1.24 (0.3~5.5) 0.90 (0.2~4.1)
Body Mass Index 485,080 77
<18.5 kg/m2 39,565 22 4.98 * (2.9~8.6) 9.67 * (4.3~21.7)
18.5 -< 23 kg/m2 214,250 33 1 - 1 -
23 -< 25 kg/m2 98,734 7 0.29 * (0.1~0.7) 0.39 (0.1~1.4)
25 -< 30 kg/m2 113,897 12 0.40 * (0.2~0.8) 0.43 (0.1~1.4)
30 kg/m2 18,634 3 0.96 (0.3~3.1) 1.17 (0.1~9.1)
Diabetes 486,341
No diabetes (by history or by screening) 462,351 63 1 - 1 -
Screened|| or known diabetes or on medications 23,990 14 1.76 (1.0~3.2) 1.89 * (1.1~3.4)
*: p < 0.05
† : HR adjusted for age and gender
‡ : HR: adjusted for age, gender, education, drinking and smoking
§: Age-specific mortality rate in Taiwan (annual per 100,000) was shown here instead of directly calculating mortality from the cohort because the number of TB deaths in this cohort followed 
up even for 14 years was too small to be stable.
||: Fasting glucose  126 mg/dLWen et al. BMC Infectious Diseases 2010, 10:156
http://www.biomedcentral.com/1471-2334/10/156
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than those relative risks reported outside of India, rang-
ing from 1.03-2.54 [2]. The magnitude of smoking risks
and the substantial reduction upon quitting found from
this cohort study has important practical implications.
First, the lukewarm attitude by the clinicians toward the
TB/smoking relationship will substantially improve,
because the evidence is now based on mortality and not
just active TB disease. The finding in this cohort that
smoking worsened the rate of TB mortality and cessation
reduced TB mortality will send a different message and
may change clinicians' perspectives toward smoking ces-
sation. Second, previous studies established a relationship
between smoking and TB mostly based on case control
studies where the selection of appropriate controls, a crit-
ical element in the study process, has been difficult. A
review article found this problem ubiquitous in TB/
smoking studies and emphasized that (hospital- or clinic-
based sampling may lead to over-representation of smok-
ers among the controls, thereby biasing the results
toward the null) [2]. This analysis explains, at least in
part, the size of the risks identified in this study were
larger than those from case control [1]. Third, our data
distinguishing those who reported a history of TB from
those unaware, showing similar but graded mortality
risks, and the substantial benefits observed for both
groups added strength and provided consistency to the
TB/smoking relationship.
That more than one-third of TB deaths were attribut-
able to smoking (37.7%) adds to the long litany of smok-
ing hazards in Asian countries [24]. The two calculations
of TB deaths attributable to smoking reported from
India, 61% [18], or 38% (males) [28], were both based on a
case control study, and 32.8%, reported from Hong Kong
[11], on incidence and not mortality. By and large, our
calculation of the deaths attributable to smoking, 37.7%
for current smokers, was not that much different from
those reported for active diseases.
One surprising finding was that significantly fewer
smokers reported TB history and proportionately more
unaware of having TB than those who had never smoked.
On the surface, this appeared to contradict the notion
that smokers have more TB infection [17]. This paradoxi-
cal phenomenon, however, confirmed our fear that smok-
ers were less vigilant regarding the potential onset of TB.
Partly because of fewer contacts with medical profession-
als, and partly because TB and smoking shared many
clinical symptoms, smokers were less informed of the TB
risk. This oversight, by smokers and their doctors alike,
has important implications, because TB in smokers in
this society was found at a later stage or in a more serious
condition than in those who had never smoked, leading
to the higher mortality rate [1].
In addition to smoking, passive smoking is a potential
confounder [29] and in the absence of these data, their
impact on susceptibility to TB infection is unknown.
However, the concentrations of second-hand smoke to
which humans are exposed to are considered to be of far
less than that of active smoking. Alcohol drinking has
also been reported to be an independent risk factor for
active TB [30,31]. We observed that drinking was associ-
ated with more TB history and a tendency to increase
subsequent TB mortality in all categories of drinkers,
including occasional, ex- and regular drinkers. The failure
to reach significance in mortality can be the result of
inadequate sample size, but the predominant style of
social drinking with meals in Taiwan may have reduced
the drinking risks as previously reported from India [31].
The implication that smoking increased TB mortality
and quitting reduced that risk can be explained in part by
the known hazards of smoking and in part by the delayed
treatment for smokers with TB. Smokers' medical condi-
tions often can be complicated by the presence of co-
morbidities, such as chronic obstructive pulmonary dis-
ease (COPD), increased infection with reduced immu-
nity, or malnutrition. COPD may play an important role
in the relationship between smoking and TB. As a large
number of smokers develop COPD, which impairs the
respiratory system and masks the physical signs of TB,
the smokers may become less aware of TB. At the same
time, in patients with both TB and smoking-related
Table 4: Smoking attributable fraction for tuberculosis mortality
N Smoking Prevalence‡ HR† 95% CI Smoking Attributable Fraction§
Current smoker 90,580 25.55% 3.37 (1.4~8.1) 37.7%
Ex-smoker 23,787 3.65% 2.02 (0.7~6.0) 6.9%
Non- smoker 270,488 1.00
Total 44.6%
† : HR adjusted for age, gender, education and drinking, BMI and DM history with nonsmokers as reference group (from table 2)
‡ : Smoking prevalence from Wen et al. [25]
§: Smoking attributable fraction = Prevalence*(HR - 1)/{1 + [Prevalence*(HR - 1)]}Wen et al. BMC Infectious Diseases 2010, 10:156
http://www.biomedcentral.com/1471-2334/10/156
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COPD, the severity of disease may be aggravated, which
may accelerate mortality and lead to increased TB mor-
tality among smokers as shown in this study. Further-
more, the underweight individuals (BMI < 18.5 kg/m2)
observed in our study were associated with a 10-fold
increase in TB mortality. Similar observations have been
previously reported in Hong Kong and India [32,33].
Elimination of smoking would improve the lung function,
reduce infection, restore immunity and improve general
well-being. Another implication is delayed treatment of
smokers with TB in the clinical setting [34] as smoking
and TB share similar clinical symptoms and clinicians
were misled by smoking symptoms. When smokers quit
smoking and become ex-smokers, there will be less con-
fusion of symptoms.
This study was the first to associate diabetes with
increased TB mortality (HR = 1.89), although the rela-
tionship with active TB was well known[35]. A review of
13 observation studies found the positive relationship
between diabetes and the risk of getting active TB[35],
with HR between 3.11 in one group and 1.62 in another,
with the latter nearly identical with the one in this study.
It is of concern to note that a large portion of the diabetes
cases (59%) in this study were unaware of their diabetes,
and therefore, less aware of their TB risks (Table 1).
There are important limitations in this study. First, the
cohort came from a higher social class with the ability to
pay for the screening. Therefore, it may not be fully rep-
resentative of the society. For national prevalence of
smoking or TB, cohort data needs to be standardized by
the socioeconomic status as in our previous reports.
However, as prevalence was not the focus of this study,
and hazard ratios or odds ratios were internally standard-
ized, the observed increase in smokers' TB risks can be a
reasonable estimate of the general population. In the
same vein, we used national smoking rates in calculating
the smoking attributable TB mortality, and thus, the
resulting estimate should also be valid. Second, mortality
from TB was determined based on death certificates and
not confirmed in any other way. The likely direction of
error should come more from omission than commission,
i.e. from deaths assigned to causes other than TB when
TB was the underlying cause. For example, if an HIV pos-
itive patient died with TB, HIV is more likely to be
recorded as the cause of death [36]. Consequently, the
hazard ratios and the percentage of deaths attributable to
smoking, 41.4%, developed in this study could have been
under-estimated. Third, a number of TB deaths did not
r e c o r d  s m o k i n g  s t a t u s  i n  t h e  e a r l y  p a r t  o f  t h e  c o h o r t
recruitment. This has substantially reduced the number
of TB deaths associated with smoking. However, our con-
clusion was based on the actual data, significance was
found after statistical treatment, even though limited
sample size failed to show dose response relationship
between smoking quantity or intensity and TB mortality
risks in Table 2. Fourth, TB history data were self-
reported and not clinically confirmed. While under-
reporting of TB history could have existed, most of them
should be unintentional, as participants in this study, hav-
ing paid a sizable fee to be screened, were genuinely inter-
ested in uncovering medical problems and thus would
volunteer as much medical information as possible for an
accurate evaluation. As there is no reason for smokers to
have different reporting mechanism from never smokers,
our study result showing a low awareness of TB among
smokers in this cohort were valid. The value of this TB
history became obvious when a striking difference in
mortality outcome was found. Fifth, the benefits of smok-
ing cessation were assumed in this study by comparing
the difference in TB mortality between smokers and ex-
smokers as separate groups and not in a before/after
manner for the given smokers. However, this assumption
is commonly made in tobacco research and this compari-
son method is widely practiced. In general, smokers don't
change their behavior patterns unless there is a pressing
medical condition. Some participants may be smokers at
the enrollment and later on quit smoking, and vice versa.
However, the proportions of people started or quit smok-
ing are relatively low. Moreover, some low-risk partici-
pants were misclassified as high-risk participants and
thus the relative risk for TB mortality calculated in this
study would more likely be over-estimated.
To assess the benefits in a before/after comparison
requires clinical trials on smokers randomly assigned to
cessation/no cessation group. Because of the paucity of
TB deaths and the associated ethical considerations, con-
ducting such a trial would be a monumental challenge.
Conclusion
Smokers had a very high TB mortality rate, as much as
nine times higher than those who had never smoked, but
once they quit, the TB mortality rate reduced substan-
tially (65%) and was similar to those who never smoked.
Smoking cessation has benefits to the smoking individual
far beyond reducing TB risk, but successful tobacco con-
trol could favorably impact the TB mortality rate and
reduce this public health burden, as smoking cessation
could reduce nearly one-third of tuberculosis deaths. Cli-
nicians should be more alert about reducing the TB risk
among smokers, since smokers and TB patients share
clinical symptoms and TB among smokers was more dif-
ficult to identify than among never smokers.
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